Qbrelis Interactions
There are 403 drugs known to interact with Qbrelis (lisinopril), along with 7 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 44 are major, 329 are moderate, and 30 are minor.
- View all 403 medications that may interact with Qbrelis
- View Qbrelis alcohol/food interactions (2)
- View Qbrelis disease interactions (7)
Most frequently checked interactions
View interaction reports for Qbrelis (lisinopril) and the medicines listed below.
- acetaminophen
- acetaminophen / hydrocodone
- acetazolamide
- Aciphex (rabeprazole)
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- albuterol / ipratropium
- alfuzosin
- Allegra (fexofenadine)
- alpha-lipoic acid
- amiodarone
- amitriptyline
- amlodipine
- amoxicillin
- Arnuity Ellipta (fluticasone)
- aspirin
- Astepro (azelastine nasal)
- atenolol
- Ativan (lorazepam)
- ciprofloxacin
- Flonase (fluticasone nasal)
- gabapentin
- mupirocin topical
- Nexium (esomeprazole)
- Norliqva (amlodipine)
- oxycodone
- prednisone
- Protonix (pantoprazole)
- Singulair (montelukast)
- Vitamin D3 (cholecalciferol)
Qbrelis alcohol/food interactions
There are 2 alcohol/food interactions with Qbrelis (lisinopril).
Qbrelis disease interactions
There are 7 disease interactions with Qbrelis (lisinopril) which include:
- angioedema
- bone marrow suppression
- hemodialysis
- hyperkalemia
- hypotension
- liver disease
- renal dysfunction
More about Qbrelis (lisinopril)
- Qbrelis consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: Angiotensin Converting Enzyme Inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.